ZIZZO, CARMELA
 Distribuzione geografica
Continente #
AS - Asia 1.142
NA - Nord America 789
EU - Europa 486
SA - Sud America 205
AF - Africa 23
OC - Oceania 3
Totale 2.648
Nazione #
US - Stati Uniti d'America 752
SG - Singapore 440
CN - Cina 297
IT - Italia 180
BR - Brasile 169
VN - Vietnam 130
HK - Hong Kong 108
NL - Olanda 76
FR - Francia 70
GB - Regno Unito 42
DE - Germania 35
KR - Corea 31
IN - India 26
BD - Bangladesh 25
FI - Finlandia 25
JP - Giappone 21
CA - Canada 20
AR - Argentina 12
PL - Polonia 11
TR - Turchia 10
MX - Messico 9
ES - Italia 7
IQ - Iraq 7
ZA - Sudafrica 7
EC - Ecuador 6
ID - Indonesia 6
EG - Egitto 5
PE - Perù 5
SA - Arabia Saudita 5
SE - Svezia 5
TN - Tunisia 5
CZ - Repubblica Ceca 4
PK - Pakistan 4
PY - Paraguay 4
UA - Ucraina 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
BO - Bolivia 3
DK - Danimarca 3
GT - Guatemala 3
IL - Israele 3
LT - Lituania 3
PH - Filippine 3
RU - Federazione Russa 3
TH - Thailandia 3
UZ - Uzbekistan 3
AT - Austria 2
AZ - Azerbaigian 2
BE - Belgio 2
CL - Cile 2
GR - Grecia 2
JM - Giamaica 2
JO - Giordania 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CO - Colombia 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
HU - Ungheria 1
IE - Irlanda 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LS - Lesotho 1
LV - Lettonia 1
MM - Myanmar 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
PT - Portogallo 1
RO - Romania 1
TW - Taiwan 1
TZ - Tanzania 1
VE - Venezuela 1
Totale 2.648
Città #
Singapore 271
Santa Clara 210
San Jose 126
Hong Kong 104
Hefei 80
Ashburn 68
Beijing 68
Los Angeles 61
Lauterbourg 46
Ho Chi Minh City 42
Hanoi 31
Seoul 31
Dallas 25
São Paulo 19
Frankfurt am Main 16
Guangzhou 15
New York 15
Tokyo 15
Lappeenranta 14
Council Bluffs 13
Orem 13
Helsinki 11
Rome 11
London 10
Düsseldorf 9
Milan 8
Buffalo 7
Da Nang 7
Hyderabad 7
Naples 7
Haiphong 6
Houston 6
Montreal 6
Padua 6
Rio de Janeiro 6
San Francisco 6
Warsaw 6
Ankara 5
Cairo 5
Charlotte 5
Chennai 5
Florence 5
Portsmouth 5
Stockholm 5
Bengaluru 4
Bologna 4
Cagliari 4
Curitiba 4
Johannesburg 4
Lima 4
Minamishinagawa 4
Munich 4
Newark 4
Palermo 4
Paris 4
Redondo Beach 4
Ribeirão Preto 4
Atlanta 3
Baghdad 3
Bari 3
Belo Horizonte 3
Biên Hòa 3
Blumenau 3
Boston 3
Brasília 3
Campinas 3
Elk Grove Village 3
Erbil 3
Guatemala City 3
Hải Dương 3
Madrid 3
Mexico City 3
Natal 3
Ottawa 3
Poplar 3
Riyadh 3
Tashkent 3
Thái Nguyên 3
Toronto 3
Vancouver 3
Wroclaw 3
Amman 2
Andria 2
Baku 2
Bangkok 2
Barnet 2
Belford Roxo 2
Bexley 2
Birmingham 2
Brooklyn 2
Brussels 2
Buenos Aires 2
Changzhou 2
Chicago 2
Cincinnati 2
City of London 2
Coventry 2
Detroit 2
Dubai 2
Falkenstein 2
Totale 1.599
Nome #
miR-126-3p and miR-21-5p as Hallmarks of Bio-Positive Ageing; Correlation Analysis and Machine Learning Prediction in Young to Ultra-Centenarian Sicilian Population 102
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease 100
Highlights of Precision Medicine, Genetics, Epigenetics and Artificial Intelligence in Pompe Disease 92
Molecular and clinical studies in five index cases with novel mutations in the GLA gene. 81
Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease 79
Diagnosis of Fabry Disease Using Alpha-Galactosidase A Activity or LysoGb3 in Blood Fails to Identify Up to Two Thirds of Female Patients 78
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? 77
Pompe disease: pathogenesis, molecular genetics and diagnosis 73
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significance 69
A novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema 68
Hemochromatosis Mimicked Gaucher Disease: Role of Hyperferritinemia in Evaluation of a Clinical Case 68
Calnexin is down-regulated in Fabry disease. A possible implication in protein misfolding 66
The Identification of a Novel Pathogenic Variant of the GLA Gene Associated with a Classic Phenotype of Anderson–Fabry Disease: A Clinical and Molecular Study 66
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 66
Late-Onset Pompe Disease with Normal Creatine Kinase Levels: The Importance of Rheumatological Suspicion 65
Mutation Spectrum of GAA Gene in Pompe Disease: Current Knowledge and Results of an Italian Study 63
Gaucher Disease or Acid Sphingomyelinase Deficiency? The Importance of Differential Diagnosis 62
Novel Pathogenic Variant of Fabry Disease in a Family with Parapelvic Cysts 62
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area 61
Up-regulation of gamma-enolase in PMC from Fabry patients 57
Identification of Novel Mutations in Patients Affected by Gaucher Disease 57
De novo mutation in a male patient with Fabry disease: a case report 56
A pilot study of circulating microRNAs as potential biomarkers of Fabry disease 53
Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings. 52
Misdiagnosi di Febbre Mediterranea Familiare in pazienti con Malattia di Anderson-Fabry 52
European Biotech week 52
Fabry disease, a complex pathology not easy to diagnose 51
Diagnosing Fabry nephropathy: the challenge of multiple kidney disease 49
Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings 48
Desensitization of olipudase alfa-induced anaphylaxis in a child with chronic neurovisceral acid sphingomyelinase deficiency 48
Fabry disease and multiple sclerosis misdiagnosis: the role of family history and neurological signs. 43
High variability of fabry disease manifestations in an extended italian family 42
A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report 42
Analysis of mutations in the GLA and MEFV genes might determines a genetic variant of Fabry diseases 42
Fabry disease: a proteomic approach 41
Novel alpha-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease 40
Proteomic approach in Fabry disease: a case report 40
Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy. 40
Identification of a novel mutation in the alpha-galactosidase A gene in patients with Fabry disease 39
Misdiagnosis of familial Mediterranean fever in patients with Anderson-Fabry disease 38
Genetic screening of Fabry patients with EcoTILLING and HRM technology 37
Alterazioni introniche in soggetti con sintomatologia riconducibile alla malattia di Fabry 37
Parapelvic cysts, a distinguishing feature of renal Fabry disease. 36
Mucopolysaccharidosis Type I and α-Mannosidosis—Phenotypically Comparable but Genetically Different: Diagnostic and Therapeutic Considerations 35
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene 34
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease 34
Multiplex Ligation Probe Amplification and Sanger Sequencing: Light and Shade in the Diagnosis of Lysosomal Storage Disorders 32
VEXAS Syndrome: Genetics, Gender Differences, Clinical Insights, Diagnostic Pitfalls, and Emerging Therapies 30
Response to Simsek et al. 28
Genetic screening of Fabry patients with EcoTILLING and HRM technology. 27
Identification of a novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema. 26
Identification of a novel mutation in patients with hereditary angioedema 24
Prevalence of type I Gaucher disease in patients with smoldering or multiple myeloma: Results from the prospective, observational CHAGAL study 1
Totale 2.761
Categoria #
all - tutte 8.218
article - articoli 7.022
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.240


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202421 0 0 0 0 0 0 0 0 5 0 15 1
2024/20251.118 54 6 76 21 203 57 4 107 88 102 227 173
2025/20261.622 79 121 130 236 311 99 202 59 103 169 113 0
Totale 2.761